Cumberland Pharmaceuticals (CPIX) Depreciation & Amortization (CF) (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Depreciation & Amortization (CF) across 17 years of filings, most recently posting $1.3 million for Q1 2026.

• Depreciation & Amortization (CF) for Q1 2026 came in at $1.3 million, up 23.72% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.4 million (down 8.23% YoY), and the FY2025 annual result was $4.1 million, down 15.45% from the prior year.
• Depreciation & Amortization (CF) came in at $1.3 million for Q1 2026 at Cumberland Pharmaceuticals, up from $1.0 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $1.7 million in Q1 2022 to a low of $511483.0 in Q4 2022.
• The 5-year median for Depreciation & Amortization (CF) is $1.2 million (2023), against an average of $1.2 million.
• Across the five-year window, Depreciation & Amortization (CF) tumbled 52.51% in 2022 and soared 141.12% in 2023, its largest moves.
• Cumberland Pharmaceuticals' Depreciation & Amortization (CF) stood at $511483.0 in 2022, then jumped by 141.12% to $1.2 million in 2023, then rose by 21.34% to $1.5 million in 2024, then tumbled by 30.37% to $1.0 million in 2025, then rose by 22.5% to $1.3 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $1.3 million (Q1 2026), $1.0 million (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.